Discovery and characterization of cnidarian peptide toxins that affect neuronal potassium ion channels
Castañeda, Olga and Harvey, Alan L (2009) Discovery and characterization of cnidarian peptide toxins that affect neuronal potassium ion channels. Toxicon, 54 (8). pp. 1119-1124. ISSN 1879-3150 (https://doi.org/10.1016/j.toxicon.2009.02.032)
Full text not available in this repository.Request a copyAbstract
Peptides have been isolated from several species of sea anemones and shown to block currents through various potassium ion channels, particularly in excitable cells. The toxins can be grouped into four structural classes: type 1 with 35-37 amino acid residues and three disulphide bridges; type 2 with 58-59 residues and three disulphide bridges; type 3 with 41-42 residues and three disulphide bridges; and type 4 with 28 residues and two disulphide bridges. Examples from the first class are BgK from Bunodosoma granulifera, ShK from Stichodactyla helianthus and AsKS (or kaliseptine) from Anemonia sulcata (now A. viridis). These interfere with binding of radiolabelled dendrotoxin to synaptosomal membranes and block currents through channels with various Kv1 subunits and also intermediate conductance K(Ca) channels. Toxins in the second class are homologous to Kunitz-type inhibitors of serine proteases; these toxins include kalicludines (AsKC 1-3) from A. sulcata and SHTXIII from S. haddoni; they block Kv1.2 channels. The third structural group includes BDS-I, BDS-II (from A. sulcata) and APETx 1 (from Anthropleura elegantissima). Their pharmacological specificity differs: BDS-I and -II block currents involving Kv3 subunits, while APETx1 blocks ERG channels. The fourth group comprises the more recently discovered SHTX I and II from S. haddoni. Their channel blocking specificity is not yet known but they displace dendrotoxin binding from synaptosomal membranes. Sea anemones can be predicted to be a continued source of new toxins that will serve as molecular probes of various K+ channels.
-
-
Item type: Article ID code: 25995 Dates: DateEvent15 December 2009PublishedSubjects: Science > Chemistry
Medicine > Therapeutics. PharmacologyDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Strathprints Administrator Date deposited: 23 Aug 2010 11:33 Last modified: 12 Dec 2024 02:29 URI: https://strathprints.strath.ac.uk/id/eprint/25995